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an Lipid and Lipoprotein
oncentrations in Childhood
redict Adult Atherosclerosis?*
tephen R. Daniels, MD, PHD, FACC
enver, Colorado
ince the initial publication of the recommendations of the
ational Cholesterol Education Program (NCEP) Pediat-
ic Panel in 1992, there has been intense interest in and
oncern about the identification and treatment of lipid and
ipoprotein abnormalities in children and adolescents (1).
ome of the most important questions concerning screening
ave been the following: 1) How useful are pediatric lipid
nd lipoprotein concentrations for the prediction of adult
utcomes? 2) What adult outcomes are most important and
hich have data available to address them? 3) If screening is
o be implemented, would it be better to use a universal or
argeted strategy? 4) Is it acceptable to use a single set of cut
oints for lipids and lipoproteins across all ages in the
ediatric age group?
See page 860
In a previous publication (2) and this issue of the Journal
3), Magnussen et al. attempt to provide answers to some of
hese questions. Magnussen et al. (3) have used data from 3
arge cohort studies—the Cardiovascular Risk in Young
inns Study (Finland), the Bogalusa Heart Study (U.S.),
nd the Childhood Determinants of Adult Health Study
Australia)—all of which have followed subjects from child-
ood into young adulthood. In a previous analysis (2), they
valuated the ability of lipid and lipoprotein levels in
hildhood to predict levels in adulthood. This addresses the
ssue of tracking, or the extent to which patients are likely to
aintain their percentile rank compared with peers over
ime. They found that with a mean follow-up of 20.2 years
here was a progressive and substantial relative risk of adult
yslipidemia associated with borderline or high risk levels in
dolescence. However, there were important differences
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Department of Pediatrics, University of Colorado, Denver School ofc
edicine, Denver, Colorado. Dr. Daniels has consulted for Abbott Laboratories and
erck/Schering-Plough.cross the cohorts. For example, 77.8% of Finnish adults
ith abnormal total cholesterol levels would have been
dentified in childhood with the use of the NCEP high-risk
ut point. However, only 42.9% of Americans and 27.8% of
ustralians would have been identified using the same
pproach. The investigators were unable to provide a clear
ecommendation regarding whether universal or targeted
creening would be optimal based on these results (2). They
oted that despite tracking, approximately 60% of adoles-
ents identified as high risk would not have elevated levels of
ipids and lipoproteins in adulthood with the use of either a
niversal or targeted strategy. However, universal screening
n adolescence has reasonable sensitivity with identification
f 75% of those affected in adulthood. Interestingly, neither
he single cut point across childhood and adolescence
pproach recommended by the NCEP (1) nor the percentile
y age approach, based on distributions from the National
ealth and Nutrition Examination Survey (NHANES),
uggested by Jolliffe and Janssen (4), proved clearly better for
rediction. This was somewhat surprising because lipid and
ipoprotein levels change substantially during childhood and
dolescence, and one might anticipate that a percentile by
ge approach would be better.
In this issue of the Journal, Magnussen et al. (3) go
urther in providing more useful information on childhood
ipid screening. For this study, the outcome was carotid
ntima-media thickness (IMT). This is a more important
nd point because it reflects actual structural change in the
arotid artery, which is associated with the atherosclerotic
rocess, and it is associated with cardiovascular outcomes.
he design of this study is similar to the previous study and
ses the same 3 cohorts. Lipid and lipoprotein measure-
ents were made during the teenage years and ultrasound
easurements of the carotid IMT were made in the
arly-to-mid 1930s. The most important findings are that
easurements of low- and high-density lipoprotein choles-
erol in adolescence were important predictors of adult
arotid IMT. In fact, those with a low level of high-density
ipoprotein cholesterol during childhood had higher carotid
MT irrespective of their adult levels. They also found that
verweight and obese adolescents with dyslipidemia had
ubstantially higher carotid IMT in adulthood. This em-
hasizes that from an epidemiologic perspective, lipid and
ipoprotein levels in adolescence are important, and they are
articularly important in conjunction with obesity.
Magnussen et al. (3) also found that there was no
ifference between the NCEP single cut point and the
HANES percentile-based cut points in predicting carotid
MT in adulthood. This is similar to the result in prediction
f adult lipid and lipoprotein levels and argues in favor of
he NCEP approach because it is simple and easier to use.
Despite the associations between adolescent levels of
ipids and lipoproteins and adult carotid IMT, lipid and
ipoprotein levels in adolescence were far from perfect
linical predictors. Sensitivity was modest and specificity
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March 10, 2009:870–1 Predicting Adult Atherosclerosisas low resulting in a low positive predictive value, but
cceptable negative predictive value. This means that a
yslipidemic value in adolescence results in a high propor-
ion of false negatives. However, a normal adolescent value
or lipids and lipoproteins makes elevated carotid IMT in
dulthood unlikely. The inclusion of overweight and hyper-
ension in adolescence improved the prediction of elevated
arotid IMT in adulthood, but prediction remained low
verall.
There are some limitations with this study. Nonpartici-
ation of those eligible for follow-up ranged from 34% to
2% across the 3 cohorts. The 3 studies used different
rotocols for measurement of carotid IMT and different
ethods of lipoprotein determinations. These limitations
re often inherent in the type of combined analysis per-
ormed for this study, but they do limit the inferences that
an be made.
Although there remains an imperfect base of evidence to
etermine the optimal strategy for screening for lipids and
ipoproteins, the work of Magnussen et al. (2,3) begins to
rovide needed information. Based on their work, it appears
hat there are clear epidemiologic associations between lipid
nd lipoprotein levels in the pediatric age range and adult
utcomes including lipid levels (2) and carotid IMT (3). It
lso appears clear that the single set of cut points recom-
ended by the original NCEP pediatric panel work as well
verall as percentile-based cut points. How to best develop
screening strategy for children and adolescents is less clear.
creening in adolescents has a low positive predictive value,
ut a good negative predictive value. It is not known
hether screening at a different age or with a different lipid
easure such as non-density lipoprotein cholesterol would
ave different results. The question of whether a universal
r a targeted screening program is superior will require
dditional information. The current NCEP pediatric
creening guidelines are based on a family history of
remature cardiovascular disease, or dyslipidemia or the
resence of other risk factors such as obesity, diabetes, or
ypertension. The results of Magnussen et al. (3) support
he concept that prediction of adult carotid IMT im-
roves somewhat with the inclusion of additional risk
actors such as obesity or hypertension. It remains un-
nown if a combination of variables could improve the
erformance of targeted screening.
Implementation of a screening program requires infor-
ation on the ability to have a positive impact on the
K
eutcome once an abnormality is detected and on the
roblem of individuals who will be false positives and false
egatives. Assessment of a screening program also requires
valuation of costs associated with screening and potential
enefits related to identification and treatment of the
dentified abnormality. A screening program must also have
high level of acceptability to those being screened. Unfor-
unately, there is a smaller evidence base regarding these
ssues for lipid screening in children and the study by
agnussen et al. (3) does not address them. This is 1 reason
hy the U.S. Preventive Services Task Force found insuf-
cient evidence to recommend for or against screening for
ipids and lipoproteins in children and adolescents (5).
Some progress is being made in developing the evidence
ase needed for making recommendations regarding lipid
nd lipoprotein screening in the pediatric population. How-
ver, a substantially greater base of information is needed
hat will require additional investigation. Until the base of
vidence deepens, clinical and public health recommenda-
ions will have to be based on less than optimal evidence.
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